2014
DOI: 10.1016/j.ijpddr.2014.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Repurposing drugs for the treatment and control of helminth infections

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
127
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 166 publications
(129 citation statements)
references
References 225 publications
(237 reference statements)
0
127
0
2
Order By: Relevance
“…18 Artesunate appears to be the most promising candidate as broadspectrum drug for its non-toxic nature, stability and solubility. 19,20 The effectiveness of artesunate on trematodes is well established. The worm burden of small intestinal trematodes, heterophyids, in mice was reduced by 100 % after three days of routine medication with 200 mg/kg/day of artesunate.…”
Section: Discussionmentioning
confidence: 99%
“…18 Artesunate appears to be the most promising candidate as broadspectrum drug for its non-toxic nature, stability and solubility. 19,20 The effectiveness of artesunate on trematodes is well established. The worm burden of small intestinal trematodes, heterophyids, in mice was reduced by 100 % after three days of routine medication with 200 mg/kg/day of artesunate.…”
Section: Discussionmentioning
confidence: 99%
“…ISSN 1411-2027 poor hygiene. In connection with the countermeasures to this kind of infection, various synthetic drug has long been used especially to tackle problems in mammalian livestock, on the other hand it is also well known that certain drug residue can be very harmful for the animal production consumer (Panic et al, 2014). To date, very limited scientific information is available on the benefits natural resource of colostrum IgG in overcoming worm parasite infection (Rumokoy and Toar, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…This strategy is based on the use of an already known and/or an approved drug to treat a (completely) different disease. [37] In collaboration with Prof. Christophe Biot and Prof. Jennifer Keiser, we evaluated the potential of the organometallic antimalarial drug candidates discussed above, namely Ferroquine and Ruthenoquine (Fig. 3) as antischistosomal agents.…”
Section: Introductionmentioning
confidence: 99%